Dexcom Inc (Dexcom) designs, develops and commercializes continuous glucose monitoring (CGM) systems use by people with diabetes and healthcare providers in the hospital. The company’s major products include integrated Dexcom G6 CGM system, Dexcom Share remote monitoring system, Dexcom Real-Time API, Dexcom ONE CGM system, associated software and mobile apps. It provides Dexcom Care training to users of CGM system and other support services. The company offers products to endocrinologists, physicians, diabetes educators and others. It distributes products directly in the US, Austria, Canada, Germany, Switzerland and the UK, and also through a network of distributors in Australia, the US, New Zealand, and other countries in Asia, Europe, Africa, Latin America, and the Middle East. Dexcom is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company DexCom Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- DexCom Inc Company Overview
- DexCom Inc Company Snapshot
- DexCom Inc Pipeline Products and Ongoing Clinical Trials Overview
- DexCom Inc - Pipeline Analysis Overview
- Business Description
- DexCom Inc - Key Facts
- DexCom Inc - Major Products and Services
- DexCom Inc Pipeline Products by Development Stage
- DexCom Inc Ongoing Clinical Trials by Trial Status
- DexCom Inc Pipeline Products Overview
- ABC4D
- ABC4D Product Overview
- ABC4D Clinical Trial
- ACHIEVE mHealth App
- ACHIEVE mHealth App Product Overview
- ACHIEVE mHealth App Clinical Trial
- DexCom CGM With Accu-Chek Insulin Delivery System
- DexCom CGM With Accu-Chek Insulin Delivery System Product Overview
- DexCom CGM With Accu-Chek Insulin Delivery System Clinical Trial
- Dexcom G7 CGM System
- Dexcom G7 CGM System Product Overview
- Dexcom Hospital Continuous Glucose Monitoring System
- Dexcom Hospital Continuous Glucose Monitoring System Product Overview
- First-Gen Verily Sensor
- First-Gen Verily Sensor Product Overview
- inControl
- inControl Product Overview
- inControl Clinical Trial
- Touchscreen Receiver
- Touchscreen Receiver Product Overview
- DexCom Inc - Key Competitors
- DexCom Inc - Key Employees
- DexCom Inc - Key Employee Biographies
- DexCom Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- DexCom Inc, Recent Developments
- Jun 23, 2023: Dexcom Updates Long-Range Financial Targets
- May 03, 2023: Dexcom rtCGM is likely to be cost-saving, study suggests
- Oct 27, 2022: Dexcom Reports Third Quarter 2022 Financial Results
- Sep 29, 2022: Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30
- Aug 03, 2022: Dexcom Announces Upcoming Conference Presentation
- Jul 28, 2022: Dexcom Reports Second Quarter 2022 Financial Results
- Jul 07, 2022: Zillion partners with Dexcom to integrate continuous glucose monitoring (CGM) data with its RestoreHealth program
- May 23, 2022: Dexcom Announces Upcoming Conference Presentation
- May 10, 2022: Dexcom Announces Upcoming Conference Presentations
- Jan 04, 2022: Dexcom to Present at 40th Annual J.P. Morgan Healthcare Conference
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- DexCom Inc Pipeline Products and Ongoing Clinical Trials Overview
- DexCom Inc Pipeline Products by Equipment Type
- DexCom Inc Pipeline Products by Indication
- DexCom Inc Ongoing Clinical Trials by Trial Status
- DexCom Inc, Key Facts
- DexCom Inc, Major Products and Services
- DexCom Inc Number of Pipeline Products by Development Stage
- DexCom Inc Pipeline Products Summary by Development Stage
- DexCom Inc Ongoing Clinical Trials by Trial Status
- DexCom Inc Ongoing Clinical Trials Summary
- ABC4D - Product Status
- ABC4D - Product Description
- ABC4D - Clinical Assessment of a Novel Advanced Bolus Calculator for Type 1 Diabetes 5
- ACHIEVE mHealth App - Product Status
- ACHIEVE mHealth App - Product Description
- ACHIEVE mHealth App - ACHIEVE: Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
- DexCom CGM With Accu-Chek Insulin Delivery System - Product Status
- DexCom CGM With Accu-Chek Insulin Delivery System - Product Description
- DexCom CGM With Accu-Chek Insulin Delivery System - Evaluation of a Closed-loop System for the Treatment of Type 2 Diabetes at Home (DT2_2)
- Dexcom G7 CGM System - Product Status
- Dexcom G7 CGM System - Product Description
- Dexcom Hospital Continuous Glucose Monitoring System - Product Status
- Dexcom Hospital Continuous Glucose Monitoring System - Product Description
- First-Gen Verily Sensor - Product Status
- First-Gen Verily Sensor - Product Description
- inControl - Product Status
- inControl - Product Description
- inControl - Feasibility of Automated Insulin Delivery with an Interoperable Algorithm Using an Alternative Insulin Pump
- Touchscreen Receiver - Product Status
- Touchscreen Receiver - Product Description
- DexCom Inc, Key Employees
- DexCom Inc, Key Employee Biographies
- DexCom Inc, Subsidiaries
- Glossary
- DexCom Inc Pipeline Products by Equipment Type
- DexCom Inc Pipeline Products by Development Stage
- DexCom Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic Diabetes
- LifeScan Inc
- Abbott Diabetes Care Inc
- Roche Diagnostics International Ltd
- Medtronic Diabetes
- LifeScan Inc
- Ascensia Diabetes Care US Inc
- Becton Dickinson and Co
- Abbott Diabetes Care Inc
- Roche Diagnostics International Ltd
- Becton Dickinson and Co
- Ascensia Diabetes Care US Inc
